Arthur Easley is a Cardiology physician affiliated with University of Nebraska at Omaha. OpenAlex indexes 33 publications with 307 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
988102 Nebraska Medical Ctr
Omaha, NE 681988102
Telephone
402-559-8888Registry record last updated 26 Jun 2013.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year20251 payment
- Boston Scientific CorporationProgram year20251 payment
- Inspire Medical Systems, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
53.3%Antiarrhythmic24.7%Amiodarone Hcl39%Flecainide Acetate22%Dofetilide19%Mexiletine Hcl13%Propafenone Hcl Er8%Part D<11 patientsBeta blocker22.2%Metoprolol Succinate31%Metoprolol Tartrate27%Sotalol22%Carvedilol21%Part D<11 patients+ 3 more classes in this area
Blood & clotting
43%Factor Xa inhibitor35.3%Eliquis82%Xarelto18%Part D<11 patientsVitamin K antagonist7.7%Warfarin Sodium100%Part D<11 patientsMetabolism & gastrointestinal
3.7%Potassium supplement3.7%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Representation of obesity in contemporary atrial fibrillation ablation randomized controlled trials
Journal of Cardiovascular Electrophysiology
2024 - WOMAN REPRESENTATION IN ATRIAL FIBRILLATION ABLATION RANDOMIZED CONTROLLED TRIALS
Journal of the American College of Cardiology
2024 - Prevalence and Impact of Poorly Controlled Modifiable Risk Factors Among Patients Who Underwent Atrial Fibrillation Ablation
The American Journal of Cardiology
2023 - PREDICTORS OF AN EARLY AND LONG-TERM IMPROVEMENT IN EJECTION FRACTION AFTER ATRIAL FIBRILLATION ABLATION AMONG PATIENTS WITH CARDIOMYOPATHY
Journal of the American College of Cardiology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Stephen Rennard, MD
University of Nebraska at Omaha
Philip Bierman, MD
University of Nebraska at Omaha
Rudy Lackner, MD
University of Nebraska at Omaha
Iraklis Pipinos, MD
University of Nebraska at Omaha
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”